Document:

EX-10.1

 Exhibit 10.1 

Execution Version 

AMENDMENT NO. 5 TO FOURTH AMENDED AND RESTATED CREDIT AGREEMENT 

AMENDMENT NO. 5, dated as of August 9, 2019 (this “Amendment”), among IQVIA Inc. (formerly known as Quintiles IMS
Incorporated), a Delaware corporation (the “Parent Borrower”), IQVIA Holdings Inc., a Delaware corporation (“Holdings”), the other guarantors party hereto, Bank of America, N.A., as administrative agent and as
collateral agent (in such capacity, the “Administrative Agent”), the Term B-1 Euro Lenders party hereto, the Term B-2 Euro Lenders party hereto and the
Replacement Lender (as defined below). 
 W I T N E S S E T H: 

WHEREAS, the Parent Borrower, the Administrative Agent, the lenders from time to time party thereto (the “Lenders”) and the
other parties thereto have entered into that certain Fourth Amended and Restated Credit Agreement, dated as of October 3, 2016 (as amended, restated, supplemented or otherwise modified prior to the date hereof, the “Existing Credit
Agreement” and as amended hereby, the “Credit Agreement”); 
 WHEREAS, pursuant to Section 10.01 of the
Existing Credit Agreement and on the terms and conditions set forth herein, (i) each Lender executing the addendum attached as Annex A hereto (the “Lender Addendum”) as a Term B-1 Euro
Lender (collectively, the “Consenting Term B-1 Euro Lenders”) has agreed to reduce the interest rate applicable to all of such Lender’s Term B-1
Euro Loans in accordance with the terms and subject to the conditions set forth herein and (ii) each Lender executing the Lender Addendum as a Term B-2 Euro Lender (collectively, the “Consenting
Term B-2 Euro Lenders” and, together with the Consenting Term B-1 Euro Lenders, the “Consenting Lenders”) has agreed to reduce the interest
rate applicable to all of such Lender’s Term B-2 Euro Loans in accordance with the terms and subject to the conditions set forth herein; 

WHEREAS, each Consenting Lender has agreed that upon giving effect to this Amendment, the Loans of such Consenting Lender may be reduced in
the sole discretion of the Lead Arrangers, and such reductions shall be effected by the assignments described in Section 14(b) hereof; 

WHEREAS, each Term B-1 Euro Lender that is not a Consenting Term
B-1 Euro Lender (a “Non-Consenting Term B-1 Euro Lender”) shall be required to assign the entire amount of its
Term B-1 Euro Loans to Goldman Sachs Bank USA (in such capacity, the “Replacement Lender”) at par in accordance with Section 3.07 of the Existing Credit Agreement and, in connection with
such assignment, the Replacement Lender shall become a Lender under the Credit Agreement with respect to the Loans so assigned; provided that the time of such assignment, the Required Facility Lenders under the Term B Facility consisting of
Term B-1 Euro Loans shall have executed Lender Addenda; 
 WHEREAS, each Term B-2 Euro Lender that is not a Consenting Term B-2 Euro Lender (a “Non-Consenting Term
B-2 Euro Lender” and the Non-Consenting Term B-2 Euro Lenders, together with the
Non-Consenting Term B-2 Euro Lenders, the “Non-Consenting Lenders”) shall be required to assign the entire
amount of its Term B-2 Euro Loans to the Replacement Lender at par in accordance with Section 3.07 of the Existing Credit Agreement and, in connection with such assignment, the Replacement Lender shall
become a Lender under the Credit Agreement with respect to the Loans so assigned; provided that the time of such assignment, the Required Facility Lenders under the Term B Facility consisting of Term
B-2 Euro Loans shall have executed Lender Addenda; and 

 WHEREAS, Goldman Sachs Bank USA, Merrill Lynch, Pierce, Fenner and Smith, JPMorgan Chase
Bank, N.A., Barclays Bank PLC, Wells Fargo Securities, LLC and HSBC Securities USA, N.A. (collectively, the “Lead Arrangers”) shall act as joint lead arrangers and bookrunners with respect to this Amendment; 

NOW, THEREFORE, in consideration of the premises and for other good and valuable consideration, the sufficiency and receipt of all of which is
hereby acknowledged, the parties hereto hereby agree as follows: 
 SECTION 1. Definitions. Capitalized terms not otherwise defined
in this Amendment shall have the same meanings as specified in the Existing Credit Agreement. 
 SECTION 2. Amendments to the Existing
Credit Agreement. Pursuant to Section 10.01 of the Existing Credit Agreement, and subject to the satisfaction of the conditions precedent set forth in Section 3 hereof, effective on and as of the Amendment No. 5 Effective Date,
the Existing Credit Agreement is hereby amended to delete the stricken text (indicated textually in the same manner as the following example: stricken text), and to add the double-underlined text (indicated textually in the same manner as the following example:
double-underlined text) as set forth in the pages attached as Annex B
hereto. 
 SECTION 3. Conditions of Effectiveness. This Amendment shall become effective as of the first date (such date being
referred to as the “Amendment No. 5 Effective Date”) when each of the following conditions shall have been satisfied: 

(a) The Administrative Agent (or its counsel) shall have received (i) counterparts of this Amendment signed by the Parent
Borrower, the Guarantors, the Replacement Lender, the Administrative Agent, and (ii) Lender Addenda signed by the Consenting Term B-1 Euro Lenders and the Consenting Term
B-2 Euro Lenders. 
 (b) The Administrative Agent shall have received (x) the
legal opinion of Ropes & Gray LLP, counsel to the Loan Parties and (y) the legal opinion of Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, L.L.P., North Carolina counsel to the Loan Parties, in each case, dated as of
the Amendment No. 5 Effective Date and in form and substance reasonably satisfactory to the Administrative Agent. 
 (c)
The Administrative Agent shall have received (i) copies of each Organization Document for the Parent Borrower and each Guarantor, as applicable, and, to the extent applicable, certified as of a recent date by the appropriate governmental
official, each dated the Amendment No. 5 Effective Date or a recent date prior thereto; (ii) signature and incumbency certificates of the officers of the Parent Borrower and each Guarantor executing this Amendment; (iii) resolutions
of the Board of Directors or similar governing body of the Parent Borrower and each Guarantor approving and authorizing the execution, delivery and performance of this Amendment and certified as of the Amendment No. 5 Effective Date by its
secretary, an assistant secretary or other appropriate Person as being in full force and effect without modification or amendment and (iv) if available, a good standing certificate from the applicable Governmental Authority of the Parent
Borrower’s and each Guarantor’s jurisdiction of incorporation, organization or formation, each dated a recent date prior to the Amendment No. 5 Effective Date. 

(d) The Administrative Agent and the Lead Arrangers shall have been paid all fees payable to the Administrative Agent and the
Lead Arrangers, respectively, on the Amendment No. 5 Effective Date and, to the extent invoiced at least two (2) Business Days prior to the Amendment No. 5 Effective Date (or as otherwise reasonably agreed by the Parent Borrower), out-of-pocket expenses required to be paid by the Parent Borrower in connection with this Amendment, including the Attorney Costs of Cahill Gordon & Reindel LLP, in
accordance with Section 10.04 of the Existing Credit Agreement. 

  
 -2- 

 (e) The Administrative Agent shall have received an officer’s
certificate with respect to the Parent Borrower and the Guarantors in form and substance reasonably satisfactory to the Administrative Agent as to satisfaction of the conditions set forth in clauses (i) and (j) of this Section 3. 

(f) To the extent requested at least three (3) Business Days prior to the Amendment No. 5 Effective Date (or as
otherwise reasonably agreed by the Parent Borrower), any requesting Lender shall have received a Note executed by the Parent Borrower in favor of each Term B-1 Euro Lender and Term B-2 Euro Lender requesting a Note, if any. 
 (g) The Administrative Agent shall have
received for the account of each Term B-1 Euro Lender and Term B-2 Euro Lender a fee payable in Euro equal to 0.25% of the aggregate principal amount of the Term B-1 Euro Loans and Term B-2 Euro Loans of such Term B-1 Euro Lender or Term B-2 Euro Lender, as
applicable, as of the Amendment No. 5 Effective Date. 
 (h) At least three (3) Business Days prior to the
Amendment No. 5 Effective Date, the Administrative Agent shall have received all documentation and other information required by regulatory authorities under applicable “know-your-customer” and anti-money laundering rules and
regulations (including a certification regarding beneficial ownership as required by the 31 C.F.R. § 1010.230), including the USA PATRIOT Act, that has been requested in writing at least ten (10) Business Days prior to the Amendment
No. 5 Effective Date. 
 (i) The representations and warranties of each Loan Party set forth in Article V of the
Existing Credit Agreement and in each other Credit Document shall be true and correct in all material respects on and as of the Amendment No. 5 Effective Date, except to the extent such representations and warranties expressly relate to an
earlier date, in which case they shall be true and correct in all material respects as of such earlier date; provided that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or
similar language shall be true and correct (after giving effect to any qualification therein) in all respects on such respective dates. 

(j) Immediately after the Amendment No. 5 Effective Date, no Default or Event of Default shall exist. 

SECTION 4. Representations and Warranties. The Loan Parties party hereto represent and warrant as follows as of the date hereof: 

(a) the execution, delivery and performance of this Amendment have been duly authorized by all necessary corporate or other
organizational action on the part of the Parent Borrower and the Guarantors. The execution, delivery and performance by the Loan Parties party hereto of this Amendment will not (i) contravene the terms of any of such Loan Party’s
Organization Documents, (ii) result in the creation of any Lien upon any of the property or assets of such Loan Party or any of the Restricted Subsidiaries (other than as permitted by Section 7.01 of the Existing Credit Agreement), or
(iii) violate any applicable Law except with respect to any breach, contravention or violation referred to in clauses (ii) and (iii), to the extent that such breach, contravention or violation would not reasonably be expected to have,
individually or in the aggregate, a Material Adverse Effect; 

  
 -3- 

 (b) this Amendment has been duly executed and delivered by each Loan Party
party hereto and constitutes a legally valid and binding obligation of each such Loan Party, enforceable against it in accordance with its terms, except as such enforceability may be limited by Debtor Relief Laws and by general principles of equity
and principles of good faith and fair dealing; and 
 (c) the representations and warranties of each Loan Party set forth in
Article V of the Credit Agreement and in each other Credit Document are true and correct in all material respects on and as of the Amendment No. 5 Effective Date, except to the extent such representations and warranties expressly relate to an
earlier date, in which case they are true and correct in all material respects as of such earlier date; provided that any representation and warranty that is qualified as to “materiality,” “Material Adverse Effect” or
similar language is true and correct (after giving effect to any qualification therein) in all respects on such respective dates. 
 SECTION
5. Effect on the Credit Agreement and the Credit Documents. 
 (a) On and after the Amendment No. 5 Effective Date, each
reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement, shall mean and be a reference to the Existing Credit Agreement, as amended by, and
after giving effect to, this Amendment. Each of the Collateral Documents, as specifically amended by this Amendment, and all of the Collateral described therein do and shall continue to secure the payment of all Obligations of the Loan Parties under
the Credit Documents, in each case, as amended by this Amendment. 
 (b) The execution, delivery and effectiveness of this Amendment shall
not, except as expressly provided herein, operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Credit Documents, nor constitute a waiver of any provision of any of the Credit Documents. On and
after the effectiveness of this Amendment, this Amendment shall for all purposes constitute a Credit Document. 
 (c) This Amendment shall
not constitute a novation of the Existing Credit Agreement or of any other Credit Document. 
 SECTION 6. Liens Unimpaired. After
giving effect to this Amendment, neither the modification of the Credit Agreement effected pursuant to this Amendment nor the execution, delivery, performance or effectiveness of this Amendment: 

(a) impairs the validity, effectiveness or priority of the Liens granted pursuant to any Credit Document prior to the Amendment
No. 5 Effective Date, and such Liens continue unimpaired with the same priority to secure repayment of all Obligations (including, without limitation, the Term B-1 Euro Loans and the Term B-2 Euro Loans), whether heretofore or hereafter incurred; or 
 (b) requires that any new
filings be made or other action taken to perfect or to maintain the perfection of such Liens. 

  
 -4- 

 SECTION 7. Execution in Counterparts. This Amendment may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute one and the same instrument. Delivery by facsimile or electronic transmission of an executed counterpart of a
signature page to this Amendment shall be effective as delivery of an original executed counterpart of this Amendment. 
 SECTION 8.
Severability. In case any provision in or obligation of this Amendment shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision
or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. 
 SECTION 9. Successors. The terms of
this Amendment shall be binding upon, and shall inure for the benefit of, the parties hereto and their respective successors and permitted assigns. 

SECTION 10. Governing Law; Jurisdiction. This Amendment shall be governed by, and construed and enforced in accordance with, the laws
of the State of New York. The provisions of Sections 10.15(b) and (c) and Section 10.16 of the Existing Credit Agreement shall apply to this Amendment, mutatis mutandis. 

SECTION 11. Lender Signatures. Each Lender that executes a counterpart to this Amendment shall be deemed to have irrevocably approved
this Amendment (and such approval shall be binding upon Lender’s successors and assigns). Each Lender agrees that such Lender shall not be entitled to receive a copy of any other Lender’s signature page to this Amendment, but agrees
that a copy of such signature page may be delivered to the Parent Borrower, the Administrative Agent and the Lead Arrangers. 
 SECTION 12.
Reaffirmation. The Parent Borrower and each Guarantor hereby expressly acknowledges the terms of this Amendment and reaffirms, as of the date hereof on behalf of themselves and each other Loan Party, (i) the covenants and agreements
contained in each Credit Document to which it is a party, including, in each case, such covenants and agreements as in effect immediately after giving effect to this Amendment and the transactions contemplated hereby and (ii) its guarantee of
the Obligations under each Guaranty, as applicable, and its prior grant of Liens on the Collateral to secure the Obligations pursuant to the Collateral Documents which Liens continue in full force and effect after giving effect to this Amendment.

 SECTION 13. Roles. It is agreed that the each Lead Arranger shall be deemed a Lead Arranger for all purposes under the Credit
Agreement. Anything herein to the contrary notwithstanding, the Lead Arrangers shall not have any powers, duties or responsibilities under this Amendment, except in their respective capacities, as applicable, as the Administrative Agent or a Lender
hereunder. 
 SECTION 14. Replacement Lender. 

(a) The Replacement Lender hereby consents to this Amendment. The Administrative Agent hereby (i) consents to this
Amendment and consents to the assignment of the then outstanding Loans of each Non-Consenting Lender to the Replacement Lender in accordance with Sections 3.07 and 10.07 of the Credit Agreement and
(ii) agrees that no assignment fees specified in Section 10.07(b) shall be required to be paid by the Parent Borrower in connection with such assignment. The Replacement Lender, the Administrative Agent and the Parent Borrower acknowledge
and agree that, upon the deemed assignment of any Loans from Non-Consenting Lenders, the Replacement Lender (i) shall become a “Lender” under, and for all purposes, and subject to and bound by
the terms, of the Credit Agreement and 

  
 -5- 

 
other Loan Documents with Loans in an amount equal to the aggregate principal amount of all Loans of the Non-Consenting Lenders assigned thereto,
(ii) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise such powers under the Credit Agreement and the other Loan Documents as are delegated to the Administrative Agent by the terms
thereof, together with such powers as are reasonably incidental thereto, (iii) shall perform all the obligations of and shall have all rights of a Lender thereunder. After the assignment of Loans by each
Non-Consenting Lender to the Replacement Lender as contemplated above, (i) the Replacement Lender shall hold (x) €115,896,904.87 of Term B-1 Euro Loans and (y)
€39,926,737.23 of Term B-2 Euro Loans and (ii)(x) the Replacement Lender and the Consenting Term B-1 Euro Lenders shall together hold all of the Term B-1 Euro Loans and (y) the Replacement Lender and the Consenting Term B-2 Euro Lenders shall together hold all of the Term B-2
Euro Loans. 
 (b) The Replacement Lender hereby agrees, and by its execution of a Lender Addendum, each Consenting Lender
agrees, that if the Term B-1 Euro Loans or Term B-2 Euro Loans of such Consenting Lender immediately prior to the Amendment No. 5 Effective Date exceed the Loans of
such Class allocated to such Lender by the Lead Arrangers, Loans of such Class in the amount of such excess shall be assigned by such Lender to the Replacement Lender, at par, upon the Amendment No. 5 Effective Date. 

[The remainder of this page is intentionally left blank] 

  
 -6- 

 IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed by their
respective officers thereunto duly authorized, as of the date first above written. 
  

			
	 IQVIA INC.,
 as the Parent
Borrower

		
	By:	 	 /s/ Eric M. Sherbet

		 	Name: Eric M. Sherbet
		 	Title:   President

 [Signature Page to Amendment No. 5] 

  

			
	IQVIA HOLDINGS INC., as a Guarantor
		
	By:	 	 /s/ Eric M. Sherbet

		 	Name: Eric M. Sherbet
		 	Title: Executive Vice President, General Counsel and Secretary

  
 [Signature Page to Amendment
No. 5] 

 
	
	APPATURE INC., as a Guarantor
	ARSENAL HOLDING COMPANY, as a Guarantor
	ARSENAL HOLDING (II) COMPANY, as a Guarantor BENEFIT HOLDING, INC., as a Guarantor
	DATA NICHE ASSOCIATES, INC., as a Guarantor IGUARD, INC., as a Guarantor
	IMS HEALTH HOLDING CORPORATION, as a Guarantor
	IMS HEALTH INVESTING CORPORATION, as a Guarantor
	IMS HEALTH INVESTMENTS, INC., as a Guarantor
	IMS HEALTH PURCHASING, INC., as a Guarantor
	IMS HOLDING INC., as a Guarantor
	IMS SOFTWARE SERVICES LTD., as a Guarantor INNOVEX MERGER CORP., as a Guarantor
	INTERCONTINENTAL MEDICAL STATISTICS INTERNATIONAL, LTD., as a Guarantor
	IQVIA CHINAMETRIK INC., as a Guarantor
	IQVIA COMMERCIAL FINANCE INC., as a Guarantor
	 IQVIA COMMERCIAL TRADING CORP., as a Guarantor 

IQVIA COMMERCIAL INDIA HOLDINGS CORP., as a Guarantor

	 IQVIA CSMS US INC., as a Guarantor 

IQVIA MEDICAL COMMUNICATIONS & CONSULTING INC., as a Guarantor 

IQVIA MEDICAL EDUCATION INC., as a Guarantor 

IQVIA PHARMA INC., as a Guarantor 
 IQVIA PHARMA
SERVICES CORP., as a Guarantor
 IQVIA RDS ASIA INC., as a Guarantor 

IQVIA RDS BT INC., as a Guarantor

	 IQVIA RDS INC., as a Guarantor 

IQVIA TRADING MANAGEMENT INC., as a Guarantor
 IQVIA
TRANSPORTATION SERVICES CORP., as a Guarantor 
 MARKET RESEARCH MANAGEMENT, INC., as a Guarantor

	 MED-VANTAGE, INC., as a Guarantor 

QCARE SITE SERVICES, INC., as a Guarantor

	THE AMUNDSEN GROUP, INC., as a Guarantor
	VCG&A, INC., as a Guarantor
	VCG-BIO, INC., as a Guarantor

 
			
		
	By:	 	 /s/ Eric M. Sherbet

		 	Name: Eric M. Sherbet
		 	Title: President

  
 [Signature Page to
Amendment No. 5] 

 
	
	 BUZZEOPDMA LLC, as a Guarantor 

EA INSTITUTE, L.L.C., as a Guarantor

	 ENTERPRISE ASSOCIATES L.L.C., as a Guarantor 

IQVIA BIOSCIENCES HOLDINGS LLC, as a Guarantor 

IQVIA BIOTECH LLC, as a Guarantor

	 IQVIA COMMERCIAL SERVICES LLC, as a Guarantor 

IQVIA MARKET INTELLIGENCE LLC, as a Guarantor 

IQVIA PHASE ONE SERVICES LLC, as a Guarantor 

IQVIA RDS LATIN AMERICA LLC, as a Guarantor 

IQVIA RDS TRANSFER LLC, as a Guarantor OUTCOME SCIENCES, LLC, as a Guarantor

	RX INDIA, LLC, as a Guarantor
	TARGETED MOLECULAR DIAGNOSTICS, LLC, as a Guarantor
	VALUEMEDICS RESEARCH, LLC, as a Guarantor

 
			
		
	By:	 	 /s/ Eric M. Sherbet

		 	Name: Eric M. Sherbet
		 	Title:   President

  
 [Signature Page to
Amendment No. 5] 

 
			
	 SPARTAN LEASING CORPORATION, as a

Guarantor

		
	By:	 	 /s/ Cathy N. LoBosco

		 	Name: Cathy N. LoBosco
		 	Title: President

 [Signature Page to Amendment No. 5] 

 
			
	 IQVIA GOVERNMENT SOLUTIONS INC., as a

Guarantor

		
	By:	 	 /s/ Michael A. Knolker

		 	Name: Michael A. Knolker
		 	Title:   Vice President

 [Signature Page to Amendment No. 5] 

 
			
	BANK OF AMERICA, N.A., as Administrative Agent
		
	By:	 	 /s/ Kevin L. Ahart

		 	Name: Kevin L. Ahart
		 	Title:   Vice President

 [Signature Page to Amendment No. 5] 

 
			
	Consented to by:
	
	GOLDMAN SACHS BANK USA, as Replacement Lender
		
	By:	 	 /s/ Charles D. Johnston

		 	Name: Charles D. Johnston
		 	Title:   Authorized Signatory

 [Signature Page to Amendment No. 5] 

 ANNEX A 

LENDER ADDENDUM1 

By executing this signature page: 

Effective Date Settlement Option 

(i) as a Consenting Term B-1 Euro Lender, the undersigned institution unconditionally
and irrevocably (x) agrees, with respect to all outstanding Term B-1 Euro Loans held by such Lender as of the Consent Effective Date (as defined below), to the terms of Amendment No. 5 to the Fourth
Amended & Restated Credit Agreement (the “Amendment”) and (y) agrees that upon giving effect to the Amendment, the Term B-1 Euro Loans of such Lender may be reduced in the sole
discretion of the Lead Arrangers, and such reductions shall be effected by the assignments described in Section 14(b) of the Amendment; and/or 

(ii) as Consenting Term B-2 Euro Lender, the undersigned institution unconditionally
and irrevocably (x) agrees, with respect to all outstanding Term B-2 Euro Loans held by such Lender as of the Consent Effective Date, to the terms of the Amendment and (y) agrees that upon giving
effect to the Amendment, the Term B-2 Euro Loans of such Lender may be reduced in the sole discretion of the Lead Arrangers, and such reductions shall be effected by the assignments described in
Section 14(b) of the Amendment. 
 Post-Effective Date Settlement Option 

(i) as a Consenting Term B-1 Euro Lender, the undersigned institution unconditionally
and irrevocably (x) agrees, with respect to all outstanding Term B-1 Euro Loans held by such Lender as of the Consent Effective Date, to the terms of the Amendment and (y) agrees that the entire
amount of such Lender’s outstanding Term B-1 Euro Loans will be assigned to the Replacement Lender at par on the Amendment No. 5 Effective Date (it being understood that no Assignment and Assumption
shall be required to be executed by such Lender to effect such assignment) and following the Amendment No. 5 Effective Date, such Lender (or its designated Affiliate, if agreed by the Replacement Lender) shall purchase by assignment Term B-1 Euro Loans in an equal principal amount as its existing Term B-1 Euro Loans or such lesser amount allocated to such Lender by the Lead Arrangers; and/or 

(ii) as a Consenting Term B-2 Euro Lender, the undersigned institution unconditionally
and irrevocably (x) agrees, with respect to all outstanding Term B-2 Euro Loans held by such Lender as of the Consent Effective Date, to the terms of the Amendment and (y) agrees that the entire
amount of such Lender’s outstanding Term B-2 Euro Loans will be assigned to the Replacement Lender at par on the Amendment No. 5 Effective Date (it being understood that no Assignment and Assumption
shall be required to be executed by such Lender to effect such assignment) and following the Amendment No. 5 Effective Date, such Lender (or its designated Affiliate, if agreed by the Replacement Lender) shall purchase by assignment Term B-2
Euro Loans in an equal principal amount as its existing Term B-2 Euro Loans or such lesser amount allocated to such Lender by the Lead Arrangers. 

 

	1 	 All capitalized terms used but not defined in this Lender Addendum shall have the meaning set forth in
Amendment No. 5 to the Fourth Amended and Restated Credit Agreement (the “Amendment”). 

  
 A-1 

 The date on which a Lender or Additional Lender executes this signature page is referred to
as the “Consent Effective Date” with respect to such Lender or Additional Lender. 

  
 A-2 

 Name of Lender: ____________________________________________________ 

 

					
	Executing as a
	
	Effective Date Settlement Option
		
	☐	 	Consenting Term B-1 Euro Lender
		
	☐	 	Consenting Term B-2 Euro Lender
		 		 	(please check all that apply)
			
		 	by	 	  

		 		 	Name:
		 		 	Title:
	
	For any Institution requiring a second signature line:
		 	by	 	  

		 		 	Name:
		 		 	Title:
	
	Post-Effective Date Settlement Option
		
	☐	 	Consenting Term B-1 Euro Lender
		
	☐	 	Consenting Term B-2 Euro Lender
		 	    (please check all that apply)
			
		 	by	 	  

		 		 	Name:
		 		 	Title:
	
	For any Institution requiring a second signature line:
		 	by	 	  

		 		 	Name:
		 		 	Title:

 Lender signature pages on file with the Administrative Agent. 

 ANNEX B 

AMENDMENTS TO EXISTING CREDIT AGREEMENT 

 by the PBGC of any liability under Title IV of ERISA with respect to the termination of any
Pension Plan or Multiemployer Plan, other than for the payment of plan contributions or PBGC premiums due but not delinquent under Section 4007 of ERISA, upon any Loan Party or any of their respective ERISA Affiliates; (g) the application
for a minimum funding waiver under Section 302(c) of ERISA with respect to a Pension Plan; (h) the imposition of a lien under Section 303(k) of ERISA with respect to any Pension Plan; (i) the occurrence of a nonexempt prohibited
transaction (within the meaning of Section 4975 of the Code or Section 406 of ERISA) which could result in liability to any Loan Party; or (j) a determination that any Pension Plan is in “at risk” status (within the meaning
of Section 303 of ERISA). 
 “EU Bail-In Legislation Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time. 

“Euro Unit” means the currency unit of the Euro. 

“Eurocurrency Rate” means: 

(a) with respect to any Eurocurrency Rate Loan denominated in Dollars or a Foreign Currency, the rate per annum equal to the offered rate
administered by the ICE Benchmark Administration Limited or such other rate per annum as is widely recognized as the successor thereto if the ICE Benchmark Administration Limited is no longer making a London Interbank Offer Rate available
(“LIBOR”), as published on the applicable Bloomberg screen page (or such other commercially available source providing such quotations as may be designated by the Administrative Agent from time to time) at approximately 11:00 a.m.,
London time, two Business Days prior to the commencement of such Interest Period, for deposits in the relevant currency (for delivery on the first day of such Interest Period) with a term equivalent to such Interest Period; and 

(b) for any rate calculation with respect to a Base Rate Loan on any date, the rate per annum equal to: LIBOR, at or about 11:00 a.m., London
time determined two Business Days prior to such date for Dollar deposits with a term of one month commencing that day; 
 provided that (i) the
Eurocurrency Rate with respect to the Term B-1 Dollar Loans and Term B-1 Euro Loans that bear interest at a rate based on
clause (a) of this definition will be deemed to be not less than 0.75% per annum, (ii) the Eurocurrency Rate with respect to the Term B-2 Euro Loans that bear interest at a
rate based on clause (a) of this definition will be deemed to be not less than 0.50% per annum, (iii) if the Eurocurrency Rate shall be less than zero, such rate shall be deemed zero for
purposes of this Agreement and (iviii) to the
extent the Eurocurrency Rate set forth in clause (a) or (b) above is not available, the Eurocurrency Rate shall be a comparable or successor rate reasonably determined by the Administrative Agent in consultation with the Parent Borrower. 

“Eurocurrency Rate Loan” means a Loan that bears interest at a rate based on clause (a) of the definition of
“Eurocurrency Rate.” 
 “Euros” means the lawful currency of the Participating Member States introduced in
accordance with the EMU Legislation. 
 “Event of Default” has the meaning specified in Section 8.01. 

“Excess Cash Flow” means, for any period, an amount equal to the excess of: 

(a) the sum, without duplication, of: 

(i) Consolidated Net Income of the Parent Borrower for such period; 

(ii) an amount equal to the amount of all non-cash charges (including depreciation and
amortization) to the extent deducted in arriving at such Consolidated Net Income, but excluding any such 

  
 -27-EX-10.2

 Exhibit 10.2 

SHARE REPURCHASE AGREEMENT 

THIS SHARE REPURCHASE AGREEMENT (this “Agreement”) is made and entered into as of this 8th day of August, 2019, by and among IQVIA Holdings Inc., a Delaware corporation (the “Purchaser”), and the selling shareholders set forth on Schedule I hereto (each, a
“Seller” and, together, the “Sellers”). 
 RECITALS 

WHEREAS, each Seller currently holds and desires to sell that number of shares of common stock of the Purchaser (the “Common
Stock”) set forth opposite such Seller’s name on Schedule I hereto (together, the “Shares”) to the Purchaser on the terms and conditions set forth in this Agreement; and 

WHEREAS, the Purchaser desires to purchase from the Sellers and the Sellers desire to sell to the Purchaser the Shares on the terms and
conditions set forth in this Agreement (the “Repurchase Transaction”). 
 NOW, THEREFORE, in consideration of the
premises and the agreements set forth below, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 

ARTICLE I 
 SALE AND
PURCHASE OF COMMON SHARES 
 Section 1.1 Purchase. Subject to the terms and
conditions of this Agreement, on August 13, 2019 or at such other time on the same or such other date as shall be mutually agreed by the parties (such date, the “Closing Date”), each of the Sellers, severally but not jointly,
shall sell, assign, transfer, convey and deliver to the Purchaser the number of Shares set forth opposite its name on Schedule I hereto, and the Purchaser shall purchase, acquire and accept such number of Shares from each of the Sellers. The
purchase price for each Share shall be $156.85 (the “Purchase Price”). 

Section 1.2 Closing. On the Closing Date, (a) each Seller shall deliver or cause to
be delivered to the Purchaser all of such Seller’s right, title and interest in and to the Shares to be sold by such Seller by an appropriate method reasonably agreed to by the Purchaser and the Sellers, together, in each case, with all
documentation reasonably necessary to transfer to Purchaser all of such Seller’s right, title and interest in and to such Shares and (b) the Purchaser shall pay to each Seller the Purchase Price for the Shares sold by such Seller in cash
by wire transfer of immediately available funds in accordance with the wire transfer instructions provided by such Seller to the Purchaser. 

  
 1 

 ARTICLE II 

REPRESENTATIONS AND WARRANTIES OF THE SELLERS 

Each of the Sellers, severally and not jointly, hereby makes the following representations and warranties to the Purchaser, each of which is
as of the date of this Agreement, and will be as of the Closing Date, true and correct. 
 Section 2.1 Existence and
Power. 
 (a) The Seller has the power, authority and capacity to execute and deliver this Agreement, to perform its obligations
hereunder, and to consummate the transactions contemplated hereby. 
 (b) The execution and delivery of this Agreement by the Seller and the
consummation by the Seller of the transactions contemplated hereby (i) do not require the consent, approval, authorization, order, registration or qualification of, or (except for filings pursuant to Section 16 or Regulation 13D under the
Exchange Act) filing with, any governmental authority or court, or body or arbitrator having jurisdiction over the Seller; and (ii) except as would not have a material adverse effect on the ability of the Seller to consummate the transactions
contemplated by this Agreement, do not and will not constitute or result in a breach, violation or default under any note, bond, mortgage, deed, indenture, lien, instrument, contract, agreement, lease or license, whether written or oral, express or
implied, to which the Seller is a party or with the Seller’s organizational documents, or any statute, law, ordinance, decree, order, injunction, rule, directive, judgment or regulation of any court, administrative or regulatory body,
governmental authority, arbitrator, mediator or similar body on the part of the Seller or cause the acceleration or termination of any obligation or right of the Seller or any other party thereto. 

Section 2.2 Valid and Enforceable Agreement; Authorization. This Agreement has
been duly authorized by the Seller, has been duly executed and delivered by the Seller and constitutes a legal, valid and binding obligation of the Seller, enforceable against the Seller in accordance with its terms, except as limited by applicable
bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and other similar laws of general application affecting enforcement of creditors’ rights generally and general principles of equity. 

Section 2.3 Title to Shares. The Seller has good and valid title to the Shares
to be sold by such Seller free and clear of any lien, encumbrance, pledge, charge, security interest, mortgage, title retention agreement, option, equity or other adverse claim, and has not, in whole or in part, (a) assigned, transferred,
hypothecated, pledged or otherwise disposed of such Shares or its ownership rights in such Shares other than, in connection with the Repurchase Transaction, to the Purchaser, or (b) given any person or entity other than, in connection with the
Repurchase Transaction, the Purchaser any transfer order, power of attorney or other authority of any nature whatsoever with respect to such Shares. 

Section 2.4 Sophistication of Seller. The Seller acknowledges and agrees that, except as
set forth in this Agreement, the Purchaser is not making any express or implied warranties in connection with the Repurchase Transaction. The Seller has such knowledge and experience in financial and business matters and in making investment
decisions of this type that it is capable of evaluating the merits and risks of making its investment decision regarding the Repurchase 

  
 2 

 
Transaction and of making an informed investment decision. The Seller has received all information it considers necessary or appropriate for deciding whether to dispose of the Shares to be sold
by such Seller. The Seller has independently investigated and evaluated the value of the Shares and the financial condition and affairs of the Purchaser and, based upon its independent analysis, the Seller has reached its own business decision to
effect the sale of Shares to be sold by such Seller contemplated hereby. The Seller is not relying on the Purchaser with respect to the tax and other economic considerations of the Repurchase Transaction, and the Seller has relied on the advice of,
or has consulted with, the Seller’s own advisors. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF THE PURCHASER 

The Purchaser hereby makes the following representations and warranties to the Sellers, each of which is as of the date of this Agreement, and
will be as of the Closing Date, true and correct. 
 Section 3.1 Existence and Power. 

(a) The Purchaser is a corporation duly organized and validly existing under the laws of the State of Delaware and has the power, authority and
capacity to execute and deliver this Agreement, to perform the Purchaser’s obligations hereunder, and to consummate the transactions contemplated hereby. 

(b) The execution and delivery of this Agreement by the Purchaser and the consummation by the Purchaser of the transactions contemplated hereby
(i) does not require the consent, approval, authorization, order, registration or qualification of, or (except for filings pursuant to Section 13 under the Exchange Act) filing with, any governmental authority or court, or body or
arbitrator having jurisdiction over the Purchaser; and (ii) except as would not have a material adverse effect on the ability of the Purchaser to consummate the transactions contemplated by this Agreement, does not and will not constitute or
result in a breach, violation or default under, any note, bond, mortgage, deed, indenture, lien, instrument, contract, agreement, lease or license, whether written or oral, express or implied, to which the Purchaser is a party, with the
Purchaser’s articles of incorporation or bylaws, or any statute, law, ordinance, decree, order, injunction, rule, directive, judgment or regulation of any court, administrative or regulatory body, governmental authority, arbitrator, mediator or
similar body on the part of the Purchaser or cause the acceleration or termination of any obligation or right of the Purchaser or any other party thereto. 

Section 3.2 Valid and Enforceable Agreement; Authorization. 

This Agreement has been duly authorized by the Purchaser, has been duly executed and delivered by the Purchaser and constitutes a legal, valid
and binding obligation of the Purchaser, enforceable against the Purchaser in accordance with its terms, except as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and other similar laws of general
application affecting enforcement of creditors’ rights generally and general principles of equity. 

  
 3 

 ARTICLE IV 

MISCELLANEOUS PROVISIONS 

Section 4.1 Notice. All notices, requests, certificates and other communications to any
party hereunder shall be in writing and shall be deemed given or made: (a) as of the date delivered, if personally delivered; (b) on the date the delivering party receives confirmation, if delivered by electronic mail; (c) three
business days after being mailed by registered or certified mail (postage prepaid with return receipt requested); or (d) one business day after being sent by overnight courier service (providing proof of delivery), to the parties at the
following addresses (or at such other address for a party as shall be specified in a notice given in accordance with this Section 4.1). 

If delivered to the Purchaser, to: 
 IQVIA
Holdings Inc. 
 100 IMS Drive 

Parsippany, New Jersey 07054 

Attention: General Counsel 
 E-mail: officeofgeneralcounsel@iqvia.com 
 If delivered to the Sellers, to the address of each Seller set forth on
Schedule I hereto. 
 Section 4.2 Entire Agreement. This Agreement embodies the entire
agreement and understanding of the parties hereto with respect to the subject matter hereof and supersedes all prior and contemporaneous oral or written agreements, representations, warranties, contracts, correspondence, conversations, memoranda and
understandings between or among the parties or any of their agents, representatives or affiliates relative to such subject matter, including, without limitation, any term sheets, emails or draft documents. 

Section 4.3 Assignment; Binding Agreement. Neither this Agreement nor any of the rights,
interests, or obligations hereunder shall be assigned, in whole or in part, by any of the parties without the prior written consent of the other parties. Subject to the preceding sentence, this Agreement and the various rights and obligations
arising hereunder shall inure to the benefit of and be binding upon the parties hereto and their respective successors and permitted assigns. Any purported assignment not permitted under this Section 4.3 shall be null and void.

 Section 4.4 Counterparts. This Agreement may be executed in multiple counterparts,
and on separate counterparts, each of which shall be deemed an original, but all of which taken together shall constitute one and the same instrument. Any counterpart or other signature hereupon delivered by facsimile or electronic transmission
shall be deemed for all purposes as constituting good and valid execution and delivery of this Agreement by such party. 

Section 4.5 Governing Law; Waiver of Jury Trial. This Agreement and all matters arising
out of or relating to this Agreement (whether in contract, tort or otherwise) shall in all respects be construed in accordance with and governed by the substantive laws of the State of New York, without giving effect to principles of conflicts of
laws. The respective agreements, representations, warranties and other statements of the Sellers and the Purchaser, as set forth in this Agreement, shall remain in full force and effect regardless of any investigation (or any

  
 4 

 
statement as to the results thereof) made by or on behalf of the Sellers or the Purchaser or any of their respective officers, directors or affiliates and regardless of whether the Sellers or the
Purchaser knew or should have known that any such representation or warranty is, was or might be inaccurate, and shall survive the Closing Date. Each party hereto waives, to the fullest extent permitted by applicable law, any right it may have to a
trial by jury in respect of any action, suit or proceeding arising out of or relating to this Agreement or any transaction contemplated hereby. 

Section 4.6 No Third Party Beneficiaries or Other Rights. This agreement is for the sole
benefit of the parties and their successors and permitted assigns and nothing herein express or implied shall give or shall be construed to confer any legal or equitable rights or remedies to any person other than the parties to this Agreement and
such successors and permitted assigns. 
 Section 4.7 Waiver; Consent. This Agreement
and its terms may not be changed, amended, waived, terminated, augmented, rescinded or discharged (other than in accordance with its terms), in whole or in part, except by a writing executed by the parties hereto. 

Section 4.8 No Broker. Except as previously disclosed in writing to each other party, no
party has engaged any third party as broker or finder or incurred or become obligated to pay any broker’s commission or finder’s fee in connection with the transactions contemplated by this Agreement. 

Section 4.9 Further Assurances. Each party hereto hereby agrees to execute and deliver, or
cause to be executed and delivered, such other documents, instruments and agreements, and take such other actions consistent with the terms of this Agreement, as may be reasonably necessary in order to accomplish the transactions contemplated by
this Agreement. 
 Section 4.11 Costs and Expenses. Each party hereto shall each pay its
own respective costs and expenses, including, without limitation, any commission or finder’s fee to any broker or finder, incurred in connection with the negotiation, preparation, execution and performance of this Agreement. 

Section 4.12 Severability. If any one or more of the provisions contained herein, or the
application thereof in any circumstance, is held invalid, illegal or unenforceable, the validity, legality and enforceability of any such provision in every other respect and of the remaining provisions contained herein shall not be affected or
impaired thereby. 
 (Signatures appear on the next page.) 

  
 5 

 IN WITNESS WHEREOF, each of the parties hereto has caused this Agreement to be executed as
of the date first above written. 
  

			
	PURCHASER:
	
	IQVIA HOLDINGS INC.
		
	By:	 	 /s/ Eric Sherbet

	Name:	 	Eric Sherbet
	Title:	 	Executive Vice President, General Counsel and Secretary

 [Signature Page to Share Repurchase Agreement] 

 
			
	 SELLERS:

		
	            	 	TPG PARTNERS V, L.P.
		 	 By: TPG GenPar V, L.P.
 its general
partner

		 	 By: TPG GenPar V Advisors, LLC
 its general
partner

		
		 	By: /s/ Adam
Fliss                                    
		 	Name: Adam Fliss
		 	Title:   Vice President
		
		 	TPG FOF V-A, L.P.
		 	 By: TPG GenPar V, L.P.
 its general
partner

		 	 By: TPG GenPar V Advisors, LLC
 its general
partner

		
		 	By: /s/ Adam
Fliss                                    
		 	Name: Adam Fliss
		 	Title:   Vice President
		
		 	TPG FOF V-B, L.P.
		 	 By: TPG GenPar V, L.P.
 its general
partner

		 	 By: TPG GenPar V Advisors, LLC
 its general
partner

		
		 	By: /s/ Adam
Fliss                                    
		 	Name: Adam Fliss
		 	Title:   Vice President
		
		 	TPG PARTNERS VI, L.P.
		 	 By: TPG GenPar VI, L.P.
 its general
partner

		 	 By: TPG GenPar VI Advisors, LLC
 its general
partner

		
		 	By: /s/ Adam
Fliss                                    
		 	Name: Adam Fliss
		 	Title:   Vice President

 [Signature Page to Share Repurchase Agreement] 

 
	
	TPG FOF VI SPV, L.P.
	 By: TPG Advisors VI, Inc.
 its general
partner

	
	By: /s/ Adam Fliss                            
	Name: Adam Fliss
	Title:   Vice President
	
	TPG BIOTECHNOLOGY PARTNERS III, L.P.
	 By: TPG Biotechnology GenPar III, L.P.
 its
general partner

	 By: TPG Biotechnology GenPar III Advisors, LLC

its general partner

	
	By: /s/ Michael LaGatta                    
	Name: Michael LaGatta
	Title:   Vice President
	
	TPG ICEBERG CO-INVEST LLC
	
	By: /s/ Adam Fliss                            
	Name: Adam Fliss
	Title:   Vice President
	
	TPG QUINTILES HOLDCO II, L.P.
	 By: TPG Advisors V, Inc.
 its general
partner

	
	By: /s/ Adam Fliss                            
	Name: Adam Fliss
	Title:   Vice President
	
	TPG QUINTILES HOLDCO III, L.P.
	 By: TPG Biotech Advisors, Inc.
 its general
partner

	
	By: /s/ Michael LaGatta                    
	Name: Michael LaGatta
	Title:   Vice President

 [Signature Page to Share Repurchase Agreement] 

 
			
	BAIN CAPITAL INTEGRAL INVESTORS 2008, L.P.
	By: Bain Capital Investors, LLC
	its general partner
		
	By:	 	 /s/ Christopher Gordon

	Authorized Signatory
	
	BCIP TCV, LLC
	By:	 	Boylston Coinvestors, LLC
	its administrative member
		
	By:	 	 /s/ Christopher Gordon

	Authorized Signatory
	
	BCIP ASSOCIATES-G
	By: Boylston Coinvestors, LLC
	as managing partner
		
	By:	 	 /s/ Christopher Gordon

		 	Authorized Signatory

 [Signature Page to Share Repurchase Agreement] 

 Schedule I 
  

					
	 TPG Sellers
	  	 Shares
	  	 Address

	TPG Partners VI, L.P.	  	289,484	  	 301 Commerce Street, Suite 3300

Fort Worth, Texas 76102
 Attention: General Counsel

Telephone: (817) 871-4000

Email: legaldept@tpg.com

	TPG FOF VI SPV, L.P.	  	1,144
	TPG Partners V, L.P.	  	289,261
	TPG FOF V-A, L.P.	  	757
	TPG FOF V-B, L.P.	  	610
	TPG Quintiles Holdco II, L.P.	  	110,390
	TPG Biotechnology Partners III, L.P.	  	11,944
	TPG Quintiles Holdco III, L.P.	  	5,776
	TPG Iceberg Co-Invest LLC	  	99,530
			
	 Bain Sellers
	  	 Shares
	  	 Address

	Bain Capital Integral Investors 2008, L.P	  	190,608	  	 c/o Bain Capital Investors, LLC
 200
Clarendon Street
 Boston, Massachusetts
 Attention: David
Hutchins
 Telephone: (617) 516-2000

Email: dhutchins@baincapital.com

	BCIP TCV, LLC	  	469
	BCIP Associates—G	  	27

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00299-of-00352.parquet"}]]